AIDS/IAS Conference
Conference Coverage
Two-drug dolutegravir treatment noninferior to 3/4 drug regimen
The fixed-dose dolutegravir-based regimen shows noninferiority versus any ART regimens, while also showing feasibility as a first-line treatment...
News
HIV-associated cryptococcal meningitis: Single-dose regimen found non-inferior
Mortality from cryptococcal meningitis with a single-dose regimen of liposomal amphotericin B is similar to the...
Conference Coverage
Twice-a-year lenacapavir shows viral suppression in drug-resistant HIV at 26 weeks
“According to its long half-life of two subcutaneous injections per year, [it] could help reduce pill burden.”
Conference Coverage
HIV: Could another two-drug regimen be on the horizon?
Conference Coverage
HIV increases risk for severe COVID-19
“We don’t have any information from this about the T-cell counts [or] the rates of viral suppression, which I think is tremendously important,”...
Conference Coverage
Resistant TB: Adjustments to BPaL regimen reduce AEs, not efficacy
Conference Coverage
Neural tube defect risk from dolutegravir drops as clinical experience grows
A troubling link between the top HIV drug dolutegravir and neural tube defects, first reported in 2018, now seems much less dangerous.
Conference Coverage
Brazilian patient in HIV remission, negative antibody test
The 35-year-old Brazilian man participated in a trial in which he received an intensified antiretroviral regimen plus supplemental vitamin B3...
Conference Coverage
Holistic HIV care broadens scope to noncommunicable diseases
Conference Coverage
COVID-19 disruptions ‘life threatening’ for people with HIV
Conference Coverage
HIV does not appear to worsen COVID-19 outcomes
“We don’t see any signs that people with HIV should take extra precautions” to protect themselves from COVID-19, said Keith Sigel, MD.
Conference Coverage
Antiretroviral-eluting implant could provide HIV prophylaxis for a year or more
The long-term islatravir implant could one day provide an easier adherence alternative for many.
Conference Coverage
U.S. HIV clinical care fails the hardest hit
Conference Coverage
On-demand and daily PrEP look similar for HIV prevention
Prospective study of more than 1,100 French MSM showed on-demand PrEP performed as well as daily PrEP for preventing HIV infection.
Conference Coverage
People with HIV develop more frailty despite treatment
AMSTERDAM – Middle-aged and elderly people with HIV developed more frailty than did similar uninfected people, and frailty predicted worse...